AKT1 and cancer: Various receptor tyrosine kinases (RTKs)—including VEGFR, PDGFR-α, EGFR, and c-Met—may be expressed or released by cancer cells and signal through the PI3K–AKT–mTOR axis to modulate tumor cell behavior.